KALOBIOS PHARMACEUTICALS INC (KBIO) has 20 open-market insider trades by 11 insiders since 2013. The most active filer is Martin Shkreli, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Martin Shkreli | 10% Owner | — | 7 | $16.6M | 2016-08-26 |
| Venture Affiliates V. Lp Sofinnova | 10% | — | 1 | $3.0M | 2013-01-31 |
| Marek Biestek | Dir | — | 3 | $710K | 2015-12-16 |
| Sanofi | — | — | 1 | $700K | 2013-01-31 |
| Partners Ii Llc Anthion | 10% | — | 1 | $507K | 2015-11-17 |
| Ventures Llc 5am | 10% | — | 1 | $500K | 2013-01-31 |
| David Moradi | Dir10% | — | 2 | $419K | 2015-12-16 |
| Bioventures Ii A/c Gbs | 10% | — | 1 | $200K | 2013-01-31 |
| Brigitte Smith | Dir | — | 1 | $200K | 2013-02-05 |
| Thomas Edward Fernandez | Dir | — | 1 | $200K | 2015-12-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Martin Shkreli | 10% Owner | Sell | $960K | 2016-08-26 |
| Martin Shkreli | 10% Owner | Sell | $5.9M | 2016-08-25 |
| Martin Shkreli | 10% | Sell | $6.9M | 2016-08-25 |
| Thomas Edward Fernandez | Director | Buy | $200K | 2015-12-16 |
| Marek Biestek | Director | Buy | $293K | 2015-12-16 |
| Michael Wayne Harrison | Director | Buy | $50K | 2015-12-16 |
Companies that share insiders with KBIO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| David Moradi | Director & 10% | Buy | $100K | 2015-12-16 |
| Martin Shkreli | CEO & 10% | Buy | $191K | 2015-11-24 |
| Martin Shkreli | CEO & 10% | Buy | $94K | 2015-11-20 |
| Marek Biestek | — | Buy | $82K | 2015-11-18 |
| David Moradi | 10% | Buy | $320K | 2015-11-18 |
| Martin Shkreli | 10% | Buy | $889K | 2015-11-18 |
| Marek Biestek | — | Buy | $335K | 2015-11-16 |
| Martin Shkreli | 10% | Buy | $1.6M | 2015-11-16 |
| Partners Ii Llc Anthion | 10% | Buy | $507K | 2015-11-16 |